Given the increasingly acknowledged implication of the JAK/STAT pathway in the modulation of pain and nociceptive response [9,10], JAKi have an additional beneficial effect of pain reduction in RA patients. This evidence concerns the gene SOAT1 and rheumatoid arthritis.